A growing school of thought within artificial intelligence suggests that the long-term competitive advantage in AI may no longer reside primarily in the models themselves. As advanced AI systems increasingly achieve similar capabilities, many experts believe that the true source of differentiation is shifting toward the proprietary, structured data that these models use for reasoning and decision-making. Operating from this perspective,

MindWalk Holdings Corp., a company focused on Bio-Native AI, has submitted a European patent application aimed at protecting the high-dimensional biological data structures that underpin its HYFT platform.

Key Highlights

Moving Beyond the AI Model
The central premise behind MindWalk's patent strategy is that AI models themselves are becoming increasingly interchangeable. As leading models continue to converge in capability, the company believes that enduring value will come from proprietary biological context and structured knowledge representations rather than from the models alone.

In June 2026, the Austin-based company announced the filing of European patent application EP26187897.9. The application targets high-dimensional representations of biological subsequences and associated property inference methodologies. Specifically, the filing aims to protect the enriched biological architecture that supports HYFT Technology, the ReefIQ biological context layer, and the LensAI reasoning environment.

According to Jennifer Bath, Ph.D., President and Chief Executive Officer of MindWalk, the long-term question in AI is not which model is being used, but rather the quality and structure of the biological information upon which the model operates. She argues that within life sciences, the differentiating factor is the underlying biological representation system that enables AI models and autonomous workflows to retrieve connected evidence, preserve provenance, and leverage accumulated knowledge across multiple research programs.

MindWalk positions its filing against a broader trend emerging in scientific AI: powerful models alone are insufficient for solving complex biological problems. The company points to publicly disclosed initiatives such as NVIDIA's BioNeMo Agent Toolkit and AstraZeneca's ChatInvent platform as examples demonstrating the importance of domain-specific knowledge, structured interfaces, provenance tracking, memory systems, and validation mechanisms in scientific AI applications.

Extending the Existing Foundation
The newly filed patent builds upon MindWalk's foundational HYFT patent (WO 2020/161344), which established a methodology for identifying recurring biological patterns across living systems and using those patterns as a searchable language for sequence comparison without traditional alignment methods.

MindWalk states that the new application protects a separate and complementary computational layer that organizes biological meaning around those recurring patterns. This layer is intended to enable reuse across the company's internal systems, customer programs, and AI-driven workflows. Rather than replacing the original patent, the company describes the new filing as protecting an additional architectural component built atop the existing foundation.

The distinction between this approach and purely model-centric AI systems forms a key part of MindWalk's thesis. While large language models can capture extensive knowledge, much of that information remains embedded within model parameters, making it difficult to inspect, update, or govern in regulated scientific environments.

MindWalk's architecture seeks to address this challenge by maintaining a biology-aware representation layer that connects meaningful biological patterns with associated sequence information, structural characteristics, physicochemical properties, functional annotations, experimental results, and literature-derived evidence. This information can then be retrieved, updated, compared, and reused as scientific knowledge evolves, without requiring complete retraining of underlying AI models.

Addressing Fragmented Biological Data
One of the persistent challenges in pharmaceutical discovery is the fragmentation of scientific information. A single research program may generate sequence data, structural analyses, physicochemical measurements, experimental results, literature references, and historical decision records that become distributed across numerous databases, teams, and software environments.

MindWalk argues that such fragmentation causes both researchers and AI systems to lose valuable contextual relationships. The company's proposed architecture is designed to preserve those relationships by maintaining links between biologically meaningful patterns and the contextual information explaining their significance.

According to Dirk Van Hyfte, M.D., Ph.D., Chief Technology Officer of MindWalk, biological understanding cannot be isolated into a single data format. Instead, sequence information, structure, function, physicochemical behavior, supporting evidence, and scientific literature must remain interconnected if AI systems are to generate meaningful insights. The company states that its patent filing aims to protect precisely this organizational framework.

Applying the Architecture to Research Programs
MindWalk reports that it has begun applying its approach within active research programs, although all results disclosed to date remain preclinical.

In dengue research, the company has reported binding-level preclinical data showing that targets identified through HYFT informed immunogen design efforts that produced antibodies capable of binding antigens from all four dengue virus serotypes across two separate studies.

Similarly, in influenza research, MindWalk has identified a functional constraint through HYFT analysis that appears across extensive influenza A and B datasets, including human, avian, swine-associated, Victoria, and Yamagata strains.

The company emphasizes that these findings remain preliminary and that substantial additional work will be required to evaluate factors such as neutralization efficacy, safety, durability, regulatory feasibility, clinical translation, and commercial viability.

This research strategy reflects what MindWalk describes as its functional and evolutionary constraint hypothesis: the idea that recurring biological patterns persist because they serve important roles related to structure, function, binding interactions, immune recognition, or evolutionary fitness. By preserving both the patterns and their surrounding context, the company aims to provide AI systems with a more transparent and biologically grounded reasoning framework.

Commercial Implications and Investor Perspective
MindWalk's commercial implementation of this strategy is embodied in its ReefIQ and LensAI platforms. The company reports that LensAI currently operates under recurring commercial agreements with life sciences customers and that the patent filing seeks to protect the foundational layer supporting those deployments as biological data and customer experience continue to accumulate.

Within the company's architecture, HYFT identifies biologically meaningful pattern anchors, ReefIQ organizes biological and customer data around those anchors within a governed context layer, and LensAI performs reasoning tasks that support target identification, candidate evaluation, hypothesis generation, and portfolio decision-making.

MindWalk believes this approach addresses a rapidly expanding market opportunity. Based on third-party industry projections cited by the company, spending on AI technologies for drug discovery could grow from approximately US$5 billion in 2026 to more than US$8 billion by 2030, complementing the pharmaceutical industry's annual research and development expenditures exceeding US$250 billion. The company notes that these figures represent external forecasts and are subject to uncertainty.

From an investment perspective, MindWalk presents the patent filing as part of a broader strategy to build value independent of any individual AI model. The company argues that its biology-aware representation layer constitutes a model-agnostic infrastructure asset whose value may increase as additional programs, datasets, and customer relationships become integrated into the system.

Broader Industry Context
MindWalk positions itself as a Bio-Native AI infrastructure company and emphasizes that comparisons with other public companies serve only as industry context.

Absci represents an approach centered on combining generative AI with synthetic biology and high-throughput laboratory validation for antibody discovery.

Certara operates within the biosimulation and model-informed drug development software market, providing a perspective on the established software infrastructure supporting pharmaceutical research.

AstraZeneca exemplifies the pharmaceutical industry's adoption of agentic AI systems within real-world discovery environments, including initiatives such as ChatInvent.

NVIDIA supplies much of the computational infrastructure and software ecosystem that powers contemporary AI applications, including tools designed specifically for life sciences research.

While these companies occupy different positions within the ecosystem, together they illustrate the breadth of technological approaches shaping AI-enabled drug discovery.

Conclusion
Filing a patent application represents the beginning of a process rather than a guarantee of protection. European patent examination may ultimately narrow, modify, or reject claims, and the eventual scope, enforceability, and commercial value of any granted patent remain uncertain. MindWalk itself acknowledges these risks, as well as the early-stage nature of its dengue and influenza programs.

Nevertheless, the company's strategic thesis remains clear: as AI models become increasingly commoditized, lasting competitive advantage in life sciences AI may derive from the structured biological knowledge systems that support those models. Through this filing, MindWalk is seeking to secure intellectual property protection around its own interpretation of that foundational layer.

For investors interested in identifying where durable value creation may occur as the AI ecosystem evolves, MindWalk's patent filing provides a noteworthy indicator. The ultimate significance of this strategy will likely depend on future patent outcomes, commercial adoption, and the company's ability to generate sustained revenue growth.

Valona Intelligence has unveiled its new Model Context Protocol (MCP) server, a solution designed to connect artificial intelligence platforms with external intelligence sources. As an open standard, MCP enables enterprise AI tools and agent frameworks—including Microsoft Copilot, Claude, and others—to access Valona's market and competitive intelligence directly within their workflows.

Artificial intelligence has become a standard component of modern business operations. According to McKinsey's 2026 research, nearly 90% of organizations now utilize AI technologies. However, as AI adoption becomes widespread, the differentiating factor is no longer access to the technology itself, but the quality and relevance of the information powering it.

"Organizations gain an advantage not from AI alone, but from the intelligence feeding those systems," said Stuart Reynish, Chief Product Officer at Valona. "Our MCP server allows enterprise AI platforms to draw upon continuously updated market and competitive insights. Rebuilding the same analysis repeatedly is both costly and inconsistent. Decision-making requires intelligence that is accurate, current, and immediately actionable."

The company believes that strategic decision-making is evolving from periodic research efforts to a model of continuous intelligence. Instead of requiring AI agents to generate analysis from raw information every time, Valona's MCP server provides access to a curated and constantly maintained intelligence foundation that is readily available whenever needed.

"The intelligence layer is the most challenging element to develop effectively, and we've spent more than twenty years refining it," said Eetu Laaksonen, Chief AI Officer at Valona. "MCP enables us to integrate that intelligence into the AI tools our customers already rely on, while also supporting the broader AI ecosystems they are building."

Laaksonen noted that interest in enterprise-wide intelligence is expanding beyond competitive market intelligence teams. "We're increasingly engaging with IT departments and senior executives because intelligence is becoming a strategic capability across the organization. Customers are telling us they want critical insights delivered proactively, rather than having to search for them."

Valona is currently working with a select group of enterprise customers to pilot the MCP server within Microsoft Copilot and agent-driven AI environments. The company plans to showcase the technology during its webinar, What Agentic AI Means for Competitive Intelligence, scheduled for June 24.

Identity security provider Silverfort has announced a new integration that brings advanced identity protection capabilities to AI agents built within Microsoft Copilot Studio. The integration enables real-time identity security enforcement, allowing organizations to apply intelligent access controls exactly when an AI agent attempts to perform an action. Unauthorized requests can be blocked before execution, helping prevent security incidents before they occur.

AI agents developed through Copilot Studio are capable of authenticating users, accessing enterprise data, initiating workflows, and interacting with systems across both cloud and on-premises environments. Since these activities are linked to human users with varying permission levels as well as multiple machine identities, they create complex authentication and authorization chains that can introduce security risks, including privilege escalation.

According to Microsoft, more than 80% of Fortune 500 organizations are actively deploying AI agents created using low-code or no-code development platforms. Additionally, nearly 29% of employees are already utilizing unsanctioned AI agents in their daily work. While business teams increasingly adopt AI solutions through platforms such as Copilot Studio, responsibility for managing associated security risks remains with identity and security leaders.

Ron Rasin, Chief Strategy Officer at Silverfort, emphasized that identity lies at the heart of AI security. He noted that AI agents become more capable as their access to enterprise resources expands, but without comprehensive identity intelligence, organizations cannot accurately determine whether an agent’s actions are legitimate or excessive. He added that Silverfort’s integration with Microsoft Copilot Studio highlights the importance of runtime identity enforcement as a critical requirement for secure AI deployment.

Real-Time Access Control at Runtime
Silverfort integrates directly with the Copilot Studio environment to provide access decisions in real time. Whenever an AI agent requests permission to use a tool, application, or function, Silverfort evaluates the request and issues an authorization decision before the action is carried out. This proactive approach helps organizations prevent unauthorized access, privilege misuse, and unintended actions before they impact business operations.

Key capabilities of Silverfort’s runtime enforcement include:

Ankur Arora, Principal Group Product Manager at Microsoft, stated that the integration extends security controls directly to the point of access. Rather than providing visibility after an action has occurred, the solution evaluates and governs every access request in real time before execution.

Unified Security Across Diverse AI Ecosystems
Most enterprises operate multiple AI platforms rather than relying on a single agent framework. As a result, organizations often manage AI agents built with Copilot Studio alongside internally developed and third-party solutions, creating fragmented security oversight.

Silverfort addresses this challenge by providing centralized visibility and identity-based controls across:

Advancing Enterprise AI Security
The Copilot Studio integration aligns with Silverfort’s broader vision of establishing identity as the primary security control layer for AI-driven enterprises. As a long-term Microsoft collaborator and former Microsoft Partner of the Year, the company continues to expand its capabilities for securing hybrid and cloud environments. Silverfort is also working closely with Microsoft on the development of additional AI-focused security innovations.

As organizations transition from AI experimentation to large-scale operational deployment, identity management is becoming the critical mechanism that governs what AI agents are permitted to do. Silverfort supports this shift by delivering identity-based enforcement at enterprise scale, processing more than 10 billion authentication events every day across over 1,000 organizations worldwide, including several Fortune 50 enterprises.

The company is also investing in AI security research, focusing on areas such as prompt injection detection and jailbreak prevention through recursive language modeling (RLM) and related technologies. By combining deep integration with Microsoft platforms, extensive identity telemetry, and ongoing AI security innovation, Silverfort aims to establish identity security as a cornerstone of the modern agentic enterprise.

Click here to know more.

As part of New York Tech Week, MuleRun hosted its event, "Go AI Native with MuleRun – Key Features Update," on June 3, bringing together professionals from fintech, e-commerce, marketing, and technology sectors to discuss the growing adoption of AI agents and what it takes for organizations to become truly AI-native.

Featured Industry Leaders
The event showcased insights from three prominent speakers:

Building an AI-Native Future with MuleRun
During his keynote presentation, Cheng Fu highlighted how AI agents have evolved from experimental concepts into practical tools deployed at scale. He emphasized that the true innovation lies not in the technology itself, but in integrating AI as a reliable and collaborative partner within teams. According to Fu, anyone can now create AI agents tailored to their specific workflows, making AI-powered productivity accessible today rather than a distant possibility.

Designed to support organizations of every size—from solo entrepreneurs and small businesses to large enterprises—MuleRun enables companies to transition toward AI-native operations. Within just eight months of launch, the platform has attracted more than one million users and continues to strengthen its presence in the enterprise market.

Panel Discussion: AI as a Partner, Not a Replacement
During the panel discussion, speakers agreed that organizations often struggle with AI adoption when they view the technology as a direct replacement for employees rather than a tool that complements human expertise. They stressed the importance of maintaining strong business fundamentals and human judgment alongside AI implementation.

Cheng Fu described AI as a highly capable analytical assistant that can automate a significant portion of repetitive work, allowing employees to focus on creativity, strategic thinking, and relationship-building. Rather than relying solely on specialized AI engineers, he encouraged companies to empower frontline employees to develop AI-driven solutions that improve their own workflows.

The panel also noted that future success will depend on professionals who combine technical proficiency with strong interpersonal and creative skills. Ultimately, the discussion concluded that AI's greatest impact will come from transforming how organizations operate. Enterprises that successfully embrace AI-native ways of working will be best positioned to unlock gains in both efficiency and innovation.

“AI should not replace human judgment—it should enhance it,” said Cheng Fu, Principal Product Manager, MuleRun.

Click here to know more.